ArticleMicrobiology spectrum2026
TIM, a novel molecular toolbox for the detection and identification of
Imane El Idrissi Saik, Kaltoum Lemkhayar, Idris Mhaidi, Sara El Mazini, Soumiya Chiheb, Anne-Laure Bañuls, Meryem Lemrani, Myriam Riyad, Baptiste Vergnes
Abstract read
In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Imane El Idrissi SaikLaboratory of Cellular and Molecular Pathology (Immunopathology of Infectious and Systemic Diseases team), Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.
Kaltoum LemkhayarLaboratory of Cellular and Molecular Pathology (Immunopathology of Infectious and Systemic Diseases team), Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.
Idris MhaidiLaboratory of Parasitology and Vector-Borne-Diseases, Institut Pasteur du Maroc, Casablanca, Morocco.
Sara El MaziniLaboratory of Parasitology and Vector-Borne-Diseases, Institut Pasteur du Maroc, Casablanca, Morocco.
Soumiya ChihebLaboratory of Cellular and Molecular Pathology (Immunopathology of Infectious and Systemic Diseases team), Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.
Anne-Laure BañulsMIVEGEC, Montpellier University, CNRS, IRD, Montpellier, France.
Meryem LemraniLaboratory of Parasitology and Vector-Borne-Diseases, Institut Pasteur du Maroc, Casablanca, Morocco.
Myriam RiyadLaboratory of Cellular and Molecular Pathology (Immunopathology of Infectious and Systemic Diseases team), Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.ORCID 0000-0002-6718-9843 Funding
Centre National pour la Recherche Scientifique et Technique PPR/2015/27H2020 Marie Skłodowska-Curie Actions 778298LabEx CeMEB ANR-10-LABX-04-01Université de Montpellier Défi clé RIVOC
6 · The paper itselfAbstract
Cutaneous leishmaniasis (CL) is the most prevalent form of leishmaniasis, with up to 1 million new cases reported annually across more than 90 endemic countries. In Morocco, CL is caused by three IMPORTANCE: This study introduces TIM, a novel molecular diagnostic assay developed to enhance the detection and species identification of
Indexed as
LeishmaniaLeishmaniasis, CutaneousMolecular Diagnostic TechniquesDNA, KinetoplastDNA PrimersDNA, ProtozoanHumansLeishmania infantumLeishmania majorLeishmania tropicaMoroccoPolymerase Chain ReactionSensitivity and SpecificityDNA, KinetoplastDNA PrimersDNA, ProtozoandiagnosisgenotypingLeishmaniaMoroccoPCR
Identifiers
PMID41342543
PMCPMC12772242
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390